The term “movement disorders” has come to be applied to those diseases of the nervous system, mostly of the basal ganglia, which cause disturbances of movement which cannot be attributed to sensory loss, weakness or spasticity, or obvious cerebellar ataxia.
2) Accuracy of clinical diagnosis of Idiopathic Parkinson’s Disease: a clinicopathological study of 100 cases / A.J. Hughes, S.E. Daniel, L. Kilford, A.J. Lees et al. // Journal of Neurology, Neurosurgery, & Psychiatry. – 1992. – Vol. 55, No. 3. – P. 181-184.
3) Bogaerts V. Genetic findings in Parkinson’s Disease and translation into treatment: a leading role for mitochondria? / V. Bogaerts, J. Theuns, C. van Broeckhoven// Genes, Brain and Behavior. – 2008. – Vol. 7, No. 2.
4) Brazis PW, Masdeu JG, Biller J (2007) Localisation in Clinical Neurology, 5th edn. Philadelphia: Lippincott Williams and Wilkins.
5) Bronstein AM, Lempert T (2007) Dizziness - A Practical Approach to Diagnosis and Management. Cambridge: Cambridge University Press.
6) Dopamine agonists and risk: impulse control disorders in Parkinson’s Disease / V. Voon, J. Gao, C. Brezing et al. // Brain. – 2011. – Vol. 134, No. 5.
7) Fowler T.J., Scadding J. W., Losseff N. (2011) Clinical Neurology. Tailor & Francis Group.
8) Kalra S. Differentiating Vascular Parkinsonism from Idiopathic Parkinson’s Disease: A Systematic Review / S. Kalra, D.G. Grosset, H.T.S. Benamer // Movement Disorders.
9) Marshall RS, Mayer SA (2007) On Call Neurology, 3rd edn. Philadelphia: Saunders.
10) Silberstein SD, Lipton RB, Dodick (2008) Wolff’s Headache and Other Head Pain, 8th edn. New York: Oxford University Press.